Gregory A. Abel

An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era

Zheng Zhou, Laurie H. Sehn, Alfred Rademaker et al. · Blood · 2013 · 953 citations

Medicine, Hematology, Oncology +14

Cost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia

Stacie B. Dusetzina, Aaron N. Winn, Gregory A. Abel et al. · Journal of Clinical Oncology · 2013 · 495 citations · Full text

Business, Insurance, Pharmacoeconomics +14

Race-Ethnic Disparities in the Impact of Stroke Risk Factors

Ralph L. Sacco, Bernadette Boden‐Albala, Gregory A. Abel et al. · Stroke · 2001 · 375 citations

Public Health, Population Health Sciences, Urban Health +16

Gait speed, grip strength, and clinical outcomes in older patients with hematologic malignancies

Michael A. Liu, Clark DuMontier, Anays Murillo et al. · Blood · 2019 · 195 citations · Full text

Medicine, Hematology, Oncology +17

American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults

Mikkael A. Sekeres, Gordon Guyatt, Gregory A. Abel et al. · Blood Advances · 2020 · 191 citations · Full text

Medicine, Hematology, Oncology +15